These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease. Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574 [TBL] [Abstract][Full Text] [Related]
15. The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease. Collins LM; Williams-Gray CH Front Psychiatry; 2016; 7():89. PubMed ID: 27242557 [TBL] [Abstract][Full Text] [Related]
16. Cognition in Parkinson's Disease. O'Callaghan C; Lewis SJG Int Rev Neurobiol; 2017; 133():557-583. PubMed ID: 28802933 [TBL] [Abstract][Full Text] [Related]
17. Cortical Thinning Associated with Age and CSF Biomarkers in Early Parkinson's Disease Is Modified by the SNCA rs356181 Polymorphism. Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J Neurodegener Dis; 2018; 18(5-6):233-238. PubMed ID: 30336481 [TBL] [Abstract][Full Text] [Related]
18. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease. Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203 [TBL] [Abstract][Full Text] [Related]
19. Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature. Fagan ES; Pihlstrøm L Eur J Neurol; 2017 Apr; 24(4):561-e20. PubMed ID: 28220571 [TBL] [Abstract][Full Text] [Related]
20. Biomarkers for cognitive impairment in Parkinson disease. Shi M; Huber BR; Zhang J Brain Pathol; 2010 May; 20(3):660-71. PubMed ID: 20522092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]